Sanofi and Parexel to study use of wearables in clinical trials

Sanofi has announced a new collaboration with Parexel that will aim to further the use of wearable devices as a means of data collection in clinical trials.

The alliance will bring together the two companies' clinical, scientific, regulatory, logistics and technical expertise to determine how wearables can optimise study performance and accelerate drug development.

In particular, they will examine how data collected from several wearable devices can be streamlined into a single, scalable data system, with a pilot study using a Parexel patient sensor solution having already been launched.

This ongoing single-site study will see patient data collected remotely and simultaneously via multiple wearable devices to demonstrate their scientific and medical viability. Publication of final study results is expected in the near future.

Lionel Bascles, global head of clinical sciences and operations at Sanofi, said: "Wearables are a core component of Sanofi's digital trials strategy, and represent an important approach to automate patient processes using the latest technologies to bring new therapies to patients sooner."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.